Extracellular Vesicles in Kidney Diseases: Moving Forward
- 18 December 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Kidney360
- Vol. 4 (2) , 245-257
Abstract
Extracellular vesicles (EVs) are evolving as novel cell mediators, biomarkers, and therapeutic targets in kidney health and disease. They are naturally derived from cells both within and outside the kidney and carry cargo which mirrors the state of the parent cell. Thus, they are potentially more sensitive and disease-specific as biomarkers and messengers in various kidney diseases. Beside their role as novel communicators within the nephron, they likely communicate between different organs affected by various kidney diseases. Study of urinary EVs (uEVs) can help to fill current knowledge gaps in kidney diseases. However, separation and characterization are challenged by their heterogeneity in size, shape, and cargo. Fortunately, more sensitive and direct EV measuring tools are in development. Many clinical syndromes in nephrology from acute to chronic kidney and glomerular to tubular diseases have been studied. Yet, validation of biomarkers in larger cohorts is warranted and simpler tools are needed. Translation from in vitro to in vivo studies is also urgently needed. The therapeutic role of uEVs in kidney diseases has been studied extensively in rodent models of AKI. On the basis of the current exponential growth of EV research, the field of EV diagnostics and therapeutics is moving forward.Keywords
This publication has 113 references indexed in Scilit:
- Microparticles and acute renal dysfunction in septic patientsJournal of Critical Care, 2013
- A translational study of urine miRNAs in acute myocardial infarctionJournal of Molecular and Cellular Cardiology, 2012
- Endosome maturationThe EMBO Journal, 2011
- Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathyProteomics, 2011
- Let-7 MicroRNA Family Is Selectively Secreted into the Extracellular Environment via Exosomes in a Metastatic Gastric Cancer Cell LinePLOS ONE, 2010
- Mesenchymal Stem Cell-Derived Microvesicles Protect Against Acute Tubular InjuryJournal of the American Society of Nephrology, 2009
- Large-Scale Proteomics and Phosphoproteomics of Urinary ExosomesJournal of the American Society of Nephrology, 2009
- Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentratorAmerican Journal of Physiology-Renal Physiology, 2007
- Epidemiology of end-stage renal disease: International comparisons of renal replacement therapyKidney International, 2000
- Expression and modulation of surface antigens in cultured rat glomerular visceral epithelial cells.Journal of Histochemistry & Cytochemistry, 1989